🇺🇸 FDA
Patent

US 10233240

Methods for treating cholestatic liver fibrosis

granted A61KA61K2039/505A61K31/575

Quick answer

US patent 10233240 (Methods for treating cholestatic liver fibrosis) held by The Regents of the University of California expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61K31/575, A61K31/7088, A61K45/06